To provide a narrative synthesis of the current evidence regarding the Fasciotens® vertical fascial traction system for managing open abdomen and complex ventral hernias, focusing on clinical, economic, organizational, and ethical aspects.
Approach:
Literature Review: A structured literature review was conducted to identify evidence on the use of Fasciotens® in patients with open abdomen or complex ventral hernias, supporting evidence-informed decision making.
Key Findings:
Fasciotens® is designed to deliver continuous vertical fascial traction, potentially increasing rates of primary fascial closure and reducing intra-abdominal pressure. The review included 18 articles focusing on clinical outcomes related to Fasciotens®.
Interpretation:
The assessment provides insights into the potential benefits and challenges of using Fasciotens® in surgical practice, though high-quality comparative studies are lacking.
Limitations:
The analysis was not designed as a formal Health Technology Assessment due to limited high-quality evidence.
Heterogeneity in study designs and outcome measures prevented quantitative meta-analysis.
Conclusion:
Further research is needed to establish the efficacy and safety of Fasciotens® in managing abdominal wall defects.
Postoperative rates of complex regional pain syndrome type 1 and pain and functional outcomes may improve among patients receiving prophylactic mecobalamin following foot and ankle surgery.
